31 results about "Prostate hypertrophy" patented technology

The present invention provides a method and composition for treatment of benign prostate hyperplasia (BPH) in men via a transscrotal delivery system. The composition of the present invention includes the steroid hormone progesterone containing permeation enhancers that greatly facilitate permeation through the skin, thus preventing modification of the constituents therein and providing continuous and sustained delivery of progesterone for several hours that mimics the circadian rhythm of endogenous progesterone. The progesterone composition preferably is capable of delivering an effective dosage amount of about 65-100 mg of progesterone per ml when applied directly onto the surface of scrotum.

The present invention relates to pharmaceutical agents which are agents for the prophylaxis or treatment of hypogonadism, male climacteric disorder, frailty, cachexia or osteoporosis; the pharmaceutical agents frailty suppressants, muscle strength enhancers, muscle increasing agents, cachexia suppressants, body weight decrease suppressants, agents for the prophylaxis or treatment of prostate hypertrophy, amyotrophy or muscle loss caused by a disease or an agent for reducing the prostate weight.The present invention also relates to methods for the prophylaxis or treatment of hypogonadism, male climacteric disorder, frailty, cachexia or osteoporosis in a mammal, which comprises administering an effective amount of the pharmaceutical agents of the present invention or a prodrug thereof; use of the pharmaceutical agents of the present invention or a prodrug thereof for the production of an agent for the prophylaxis or treatment of hypogonadism, male climacteric disorder, frailty, cachexia or osteoporosis; and the like.

The invention provides a pharmaceutical composition for preventing and treating climacteric metancholia and other diseases, relating to the field of medical technology, and particularly providing a new application of a pharmaceutical composition which is called as Qi-replenishing sharp and bright decoction and is composed of ginseng or codonopsis pilosula, astragalus membranaceus, cimicifugae foetidae, root of kudzuvine, simpleleaf shrub chastetree fruit, radix paeoniae alba, cortex phellodendri and liquorice in the preparation of a drug or food for preventing and treating climacteric metancholia, senile chronic vaginitis, senile chronic urethritis or cystitis, and senile chronic prostate hypertrophy as a main raw material. In addition, the invention further relates to an application of a new pharmaceutical composition which is obtained according to the modification of prescription of the Qi-replenishing sharp and bright decoction or the prescription of the Qi-replenishing sharp and bright decoction in the preparation of a drug or food for preventing and treating the diseases above as a main raw material. The pharmaceutical composition for preventing and treating climacteric metancholia and other diseases provided by the invention has the advantages that the raw materials of the pharmaceutical composition can be mixed after crushing to powder independently or crushed to powder after mixing, the edible preparation can be prepared directly, the raw materials can be mixed after extracting independently or extracted after mixing, and the pharmaceutical composition is prepared into all the normally used pharmaceutical dosage forms such as pills, powders, capsules, tablets, medicinal granules, oral liquids and the like together with pharmaceutically acceptable accessories.

The present invention discloses a group of plant preparations made of cassia twig (or cinnamon) for inhibiting prostate hypertrophy and releasing urinary dysfunction and a preparation method thereof. The group of plant preparations can be used as medicine, nutritional agent and food for inhibiting prostate hypertrophy and releasing urinary dysfunction.

The invention discloses compounds of Formula (1), pharmaceutically-acceptable salts, methods of making them, pharmaceutical compositions containing them and methods for their use. The compounds are neurokinin-3(NK-3) receptor antagonists and are used in the treatment of diseases such as depression, anxiety, schizophrenia, cognitive disorders, psychoses, obesity, inflammatory diseases, irritable bowel syndrome, inflammatory bowel disorder, emesis, preeclampsia, chronic obstructive pulmonary disease, disorders associated with excessive gonadotrophins and / or androgens including dysmenorrhea, benign prostatic hyperplasia, prostatic cancer and testicular cancer.

The invention relates to the field of a traditional Chinese medicine, and discloses a traditional Chinese medicine for treating hyperplasia of prostate. The traditional Chinese medicine for treating the hyperplasia of prostate is prepared from astragalus mongholicus, radix aconiti lateralis preparata, radix achyranthis bidentatae, curcuma zedoary, rhizoma alismatis, seaweed, liquorice, pangolin beads, rhizoma anemarrhenae, golden cypress, cinnamomum cassia, semen vaccariae, stir-baked turtle shell, selfheal and bulbus fritillariae thunbergii. The traditional Chinese medicine for treating the hyperplasia of prostate is good in a curative effect, short in treatment course, and high in recovery rate; and the total effective rate is 96.36%.

The invention discloses a Chinese herbal compound for treating benign prostatic hyperplasia and the preparation method. The invention is characterized in that the compound is prepared with raw materials of prunus African, pollen, dandelion and flos chrysanthemi indici (wild chrysanthemum flower) which are extracted and refined in a proper process. The invention also discloses preparation methods of various preparations which are produced with the compound and acceptable in pharmacy and applications of the preparations in the prevention field of the benign prostatic hyperplasia.

Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson's disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects.

The invention relates to a pharmaceutical preparation for hyperplasia of prostate. The pharmaceutical preparation is prepared from the following raw materials: 2.5kg of finasteride, 9.2kg of starch, 9.2kg of pregelatinized starch, 13.5kg of lactose, 11.6kg of microcrystalline cellulose, 2.5kg of sodium carboxymethyl starch, 25kg of 2% hydroxypropyl methylcellulose pulp and 0.15kg of magnesium stearate; and the raw materials are granulated by a conventional method to prepare 500,000 tablets. The product provided by the invention realizes an obvious and stable treatment effect on hyperplasia of prostate and has a broad application prospect.

The invention discloses a traditional Chinese medicinal material compound extract for reducing benign prostatic hyperplasia symptoms. The extract is prepared by taking saxifraga stolonifera and salvia miltiorrhiza as raw materials. According to the extract disclosed by the invention, the prostate gland weight of the benign prostatic hyperplasia symptoms can be obviously reduced, and the price is low.

The present invention relates to pharmaceutical agents which are agents for the prophylaxis or treatment of hypogonadism, male climacteric disorder, frailty, cachexia or osteoporosis; the pharmaceutical agents frailty suppressants, muscle strength enhancers, muscle increasing agents, cachexia suppressants, body weight decrease suppressants, agents for the prophylaxis or treatment of prostate hypertrophy, amyotrophy or muscle loss caused by a disease or an agent for reducing the prostate weight.The present invention also relates to methods for the prophylaxis or treatment of hypogonadism, male climacteric disorder, frailty, cachexia or osteoporosis in a mammal, which comprises administering an effective amount of the pharmaceutical agents of the present invention or a prodrug thereof; use of the pharmaceutical agents of the present invention or a prodrug thereof for the production of an agent for the prophylaxis or treatment of hypogonadism, male climacteric disorder, frailty, cachexia or osteoporosis; and the like.

The invention provides a drug composition for treating prostatic hyperplasia. The drug composition is composed of following components: a pygeum topengii bark extract, a urtica dioica root extract, beta-sitosterol, lycopene, zinc citrate, selenium and vitamin E. According to the drug composition for treating prostatic hyperplasia, by combining traditional Chinese medical herbs with western medicine, a compound is formed; and the drug composition rapidly comes into effect, can rapidly relieve prostatic hyperplasis symptoms and rapidly alleviate pain of patients, can achieve radical treatment and is short in treatment course, and prostatic hyperplasia does not easily relapse.

Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson's disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combinationwith at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects.

The present invention discloses one kind of Chinese medicine composition prepared with red sage, astragalus root, knotgrass, plantain seed, walnut kernel and other four kinds of Chinese medicinal materials. The Chinese medicine composition may be tablet, capsule, bolus, granule or oral liquid. The Chinese medicine composition has the functions of promoting urination, relieving stranguria, refreshing, promoting intelligence growth, invigorating kidney, improving eyesight and clearing away heat and toxic material, and may be used in preventing and treating senile dementia and prostate hypertrophy.

Select phytoestrogen pharmaceutical compositions and methods of use for preventing or reducing one or more symptoms associated with hair loss or prostate cancer / prostate hypertrophy are described herein. These select phytoestrogen formulations are preferably composed only of two or more plant-derived estrogenic molecules and / or their structural analogues and exhibit binding preference to ERβ over ERα and agonist activity in non-reproductive tissues including brain.

Select phytoestrogen pharmaceutical compositions and methods of use for preventing or reducing one or more symptoms associated with hair loss or prostate cancer / prostate hypertrophy are described herein. These select phytoestrogen formulations are preferably composed only of two or more plant-derived estrogenic molecules and / or their structural analogues and exhibit binding preference to ERβ over ERα and agonist activity in non-reproductive tissues including brain.

The invention belongs to the technical field of traditional Chinese medicines, and in particular discloses a Chinese medicine composition for treating hyperplasia of prostate and a preparation method of the Chinese medicine composition. The Chinese medicine composition is prepared from the following Chinese medicinal herbs in parts by weight: 5-10 parts of fried rhizoma atractylodis, 5-10 parts of amur cork tree bark, 5-15 parts of cortex mori radicis, 10-15 parts of plantain seed, 3-10 parts of parched pangolin, 3-10 parts of common burreed rhizome, 5-10 parts of fired semen vaccariae, 5-15 parts of lumbricus, 3-9 parts of safflower, 5-15 parts of Chinese angelica, 6-15 parts of medicinal cyathula root, 1.5-3 parts of amber, 10-60 parts of astragalus, 5-10 parts of ginseng, 3-15 parts of radix aconiti lateralis preparata and 5-10 parts of pulp of dogwood fruit. The Chinese medicine composition has the effects of clearing heat, promoting dieresis, nourishing qi, warming kidney, resolving hard lump, and dispersing blood stasis, and has quick treatment effect on the hyperplasia of prostate with definite treatment effect.

The invention discloses a prostatitis pad plaster, which belongs to the technical field of a medical plaster. The prostatitis pad plaster comprises the following raw materials in parts by weight: 30-80 parts of raspberry, 20-50 parts of plantago, 40-60 parts of dianthus superbus, 35-60 parts of polygonum aviculare, 30-60 parts of Sichuan achyranthes, 40-55 parts of Pyrrosia lingua, 38-48 of Lygodium japonicum, 20-60 parts of polyporus, 45-55 parts of dandelion, 40-60 parts of Semen Astragali Complanati, 30-60 parts of fructus rosae laevigatae, 30-68 parts of saururus chinensis, 40-55 of SemenCuscutae, and 10 to 100 parts of borneol. The prostatitis pad plaster prepared by the invention is applied in a manner that avoids the discomfort of a gel, a suppository, an umbilical paste, a physiotherapy instrument, and other external products, and the side effects caused by the medication. The prostatitis pad plaster is safer, more comfortable, non-invasive, and painless, has no side effects,and has rehabilitation and physiotherapy on prostatitis, prostate hypertrophy syndrome.

The present invention relates to a Chinese herbal medicine for treating prostatitis, which is prepared by the raw materials of Chinese angelica, medicinal cyathula root, salvia, common burreed rhizome, zedoary, yanhusuo, centipede, Mongolian dandelion herb, membranous milkvetch root, pangolin scales, nutgrass galingale rhizome, fennel fruit and pilose Asiabell root; the present invention can treat and radically cure prostate hypertrophy, inflammation and hyperplasia, while the present invention also has good efficacy for urethral stones.

The present invention provides a compound represented by the following general formula (I):or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing such a compound, and the like. The compound or a pharmaceutically acceptable salt thereof, the pharmaceutical composition containing such a compound, or the like is useful as a medicine or the like for therapy of benign prostatic hyperplasia, cancer, osteoporosis, psoriasis, secondary hyperparathyroidism, chronic glomerulonephritis, lupus nephritis and / or diabetic nephropathy and the like.

The present invention discloses one kind of Chinese medicine composition prepared with red sage, astragalus root, knotgrass, plantain seed, walnut kernel and other four kinds of Chinese medicinal materials. The Chinese medicine composition may be tablet, capsule, bolus, granule or oral liquid. The Chinese medicine composition has the functions of promoting urination, relieving stranguria, refreshing, promoting intelligence growth, invigorating kidney, improving eyesight and clearing away heat and toxic material, and may be used in preventing and treating senile dementia and prostate hypertrophy.

The invention relates to the technical field of health products, in particular to a medicinal and edible health-care composition for nursing prostates and improving sexual function, and a preparationmethod thereof. The medicinal and edible health-care composition comprises, by weight, 20-30 parts of oyster aqueous extract, 15-25 parts of Chinese wolfberry extract, 10-18 parts of cinnamon, 5-10 parts of herba epimedii, 3-7 parts of rhizoma polygonati, 4-8 parts of radix astragali, 3-7 parts of yams, 2-6 parts of fructus alpiniae oxyphyllae, 2-5 parts of selenium-rich konjac flour, 3-6 parts ofmaltodextrin and 0.1-0.5 part of multivitamin. The medicinal and edible health-care composition has the advantages that medicinal and edible components such as the oyster extract, the Chinese wolfberry extract, the cinnamon, the herba epimedii, the rhizoma polygonati, the radix astragali, the yams and the fructus alpiniae oxyphyllae are selected and then blended with essential trace elements, including selenium and zinc, and the multivitamin to achieve the synergistic effect; after the health product is eaten, aging of reproductive systems can be relieved, prostate cancer can be prevented, and prostate hypertrophy and male sexual dysfunction can be relieved; the composition free of toxic and side effects is a high-quality health food.

The invention relates to a traditional Chinese medicine preparation for treating hyperplasia of prostate and a preparation method thereof. The traditional Chinese medicine preparation is prepared from the following crude drugs in parts by weight: 8-15 parts of ground beetle, 7-14 parts of herba lysimachiae, 5-11 parts of centella asiatica, 3-11 parts of radix dipsaci, 8-17 parts of portulaca oleraceal, 4-10 parts of astragalus membranaceus, 3-12 parts of leeches, 4-14 parts of radix rehmanniae preparata, 6-12 parts of dandelion, 5-10 parts of dragon bone, 2-9 parts of andrographis paniculata, 2-7 parts of polygala tenuifolia and 8-13 parts of eucommia ulmoides. According to the traditional Chinese medicine preparation for treating hyperplasia of prostate and the preparation method thereof, provided by the invention, the treating effect on hyperplasia of prostate is obvious, and at the same time the efficacies of strengthening tendons and bones, delaying senescence and improving body immunity are achieved; besides, the traditional Chinese medicine preparation has the characteristics of being unique in formula and reasonable in compatibility, is further easy in operation and preparation, free of the toxic and side effect, and particularly suitable for being taken by patients, especially senile patients.

The invention discloses a traditional Chinese medicine for treating benign prostatic hyperplasia with kidney deficiency and blood stasis and a preparation method for bladder detrusor dysfunction. The traditional Chinese medicine includes the following raw materials: Cuscuta 15-30g, Cornus officinale 14-16g, Golden Cherry 14-16g, burnt dragon bone 20-30g, leek seeds 15-20g, astragalus 30-45g, amber 2.5-3.5g, blanched leech 3-5g, Aphrodisiac 15-20g, mulberry octopus 10-15g, soybean herb 20‑30g, Sichuan Achyranthes 14‑16g. The invention is made of pure natural raw materials and Chinese medicines. Various medicines are organically coordinated, synergistic, reasonably formulated, rich in raw materials, simple in method, convenient to take, good in curative effect and low in cost. It is an ideal method for treating benign prostatic hyperplasia and bladder pressure. A major innovation in the treatment of urinary muscle dysfunction.

The invention belongs to the technical field of medicine preparation, and particularly relates to a medicine composition for treating benign prostatic hyperplasia and a preparation method thereof. The pharmaceutical composition for treating benign prostatic hyperplasia is prepared from the following components in parts by weight: 39 to 56 parts of plant extract, 6 to 10 parts of decanoyl acetaldehyde, 7 to 12 parts of tanshinone and 2 to 8 parts of paeonol. The pharmaceutical composition for treating the prostatic hyperplasia can quickly relieve the symptoms of the prostatic hyperplasia, takes effect quickly, has the total effective rate of 91%, is short in treatment course and not prone to relapse, quickly relieves the pain of a patient, and treats the prostatic hyperplasia from multiple aspects and multiple targets.

The invention relates to the field of the formula of the medicine, in particular to a medicinal decoction used for treating prostate hyperplasia. The preparation method comprises the following steps: adopting cinnamon, scaly anteater, radix cyathulae, the carda part of radix angelicae sinensis root, earthworm, plantain seed and rhizoma acori graminei as raw materials, soaking with water, then decocting and deslagging to obtain filtrate. The medicinal decoction is technically characterized by comprising the following raw materials by weight percent: 8-12% of cinnamon, 17-23% of scaly anteater,12-18% of radix cyathulae, 11-19% of the carda part of radix angelicae sinensis root, 12-18% of earthworm, 12-18% of plantain seed and 8-12% of rhizoma acori graminei. The medicinal decoction for treating the prostate hyperplasia has low cost, high curative effect for treating the prostate hyperplasia and no toxic or side effect.

The invention relates to the field of medicines for treating hyperplasia of prostate, and particularly discloses a medicine composition for treating hyperplasia of prostate, soothing gel and a preparation method of the soothing gel. The pharmaceutical composition is prepared from the following raw materials in percentage by weight: 12 to 17 percent of pyrrosia lingua, 12 to 17 percent of plantain herb, 12 to 17 percent of cinnamon, 12 to 16 percent of radix cyathulae, 0.80 to 0.87 percent of sophocarpidine, 8 to 12 percent of maca, and 0.12 to 0.18 percent of menthol, with the balance being herba epimedii. The soothing gel is prepared from the following raw materials in parts by weight: 170 to 200 parts of the pharmaceutical composition for treating prostatic hyperplasia, 12 to 15 parts of carbomer, 12 to 15 parts of triethanolamine, 2 to 3 parts of ethylparaben, 0.5 to 1.5 parts of benzalkonium bromide, 8 to 10 parts of sodium hyaluronate, 10 to 13 parts of glycerol, and 5 to 8 parts of peppermint essential oil, with the balance being purified water and the total being 1000 parts. The pharmaceutical composition has the effect of improving the symptoms of the prostatic hyperplasia, and the soothing gel has the effect of accelerating the improvement of the symptoms of the prostatic hyperplasia.

The invention relates to underpants locally keeping warm for old men suffering from prostatic hyperplasia. A cloth bag of which the opening facing upwards is formed in the right center of the inner side of the front part of the underpants for storing proper fabrics for keeping warm, the cloth bag makes an effect of locally keeping warm on a lower abdomen and a micturating (genital) system, and the other parts are the same as common clothes. The underpants do not influence the movements of running, jumping, skipping or kicking, of the old men; a layer of warmth can be generated at the locally warm-keeping position, so that the scrotum never shrinks, and severe cold does not influence the old men. When the old men sleep at night, the positions of bodies usually change, air convection is generated in mattress, the old men can feel cold, but the locally warm keeping can effectively prevent cold from urinary tract stimulation, so that the old men can be relieved to sleep.

The invention relates to the field of a traditional Chinese medicine, and discloses a traditional Chinese medicine for treating hyperplasia of prostate. The traditional Chinese medicine for treating the hyperplasia of prostate is prepared from astragalus mongholicus, radix aconiti lateralis preparata, radix achyranthis bidentatae, curcuma zedoary, rhizoma alismatis, seaweed, liquorice, pangolin beads, rhizoma anemarrhenae, golden cypress, cinnamomum cassia, semen vaccariae, stir-baked turtle shell, selfheal and bulbus fritillariae thunbergii. The traditional Chinese medicine for treating the hyperplasia of prostate is good in a curative effect, short in treatment course, and high in recovery rate; and the total effective rate is 96.36%.